• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A-to-I RNA 编辑预测肝癌的临床预后并与免疫细胞浸润相关。

A-to-I RNA co-editing predicts clinical outcomes and is associated with immune cells infiltration in hepatocellular carcinoma.

机构信息

School of Food and Biological Engineering, Hefei University of Technology, Hefei, 230009, China.

Department of Endocrinology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430014, Hubei, China.

出版信息

Commun Biol. 2024 Jul 9;7(1):838. doi: 10.1038/s42003-024-06520-y.

DOI:10.1038/s42003-024-06520-y
PMID:38982182
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11233613/
Abstract

Aberrant RNA editing has emerged as a pivotal factor in the pathogenesis of hepatocellular carcinoma (HCC), but the impact of RNA co-editing within HCC remains underexplored. We used a multi-step algorithm to construct an RNA co-editing network in HCC, and found that HCC-related RNA editings are predominantly centralized within the network. Furthermore, five pairs of risk RNA co-editing events were significantly correlated with the overall survival in HCC. Based on presence of risk RNA co-editings resulted in the categorization of HCC patients into high-risk and low-risk groups. Disparities in immune cell infiltrations were observed between the two groups, with the high-risk group exhibiting a greater abundance of exhausted T cells. Additionally, seven genes associated with risk RNA co-editing pairs were identified, whose expression effectively differentiates HCC tumor samples from normal ones. Our research offers an innovative perspective on the etiology and potential therapeutics for HCC.

摘要

RNA 编辑异常已成为肝细胞癌 (HCC) 发病机制中的关键因素,但 HCC 内 RNA 共编辑的影响仍未得到充分探索。我们使用多步算法构建了 HCC 的 RNA 共编辑网络,发现 HCC 相关的 RNA 编辑主要集中在网络内。此外,五对与 HCC 总体生存率显著相关的风险 RNA 共编辑事件。基于存在风险 RNA 共编辑,将 HCC 患者分为高危组和低危组。两组之间观察到免疫细胞浸润的差异,高危组衰竭 T 细胞的丰度更高。此外,还鉴定出与风险 RNA 共编辑对相关的七个基因,其表达可有效区分 HCC 肿瘤样本与正常样本。我们的研究为 HCC 的病因学和潜在治疗方法提供了新的视角。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef3/11233613/d4b71c486eb5/42003_2024_6520_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef3/11233613/5da3fd73c923/42003_2024_6520_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef3/11233613/7bec0648c14b/42003_2024_6520_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef3/11233613/4c0677c4df4d/42003_2024_6520_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef3/11233613/c6bc2061f128/42003_2024_6520_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef3/11233613/889a2f64ae07/42003_2024_6520_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef3/11233613/fbacc5125f59/42003_2024_6520_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef3/11233613/d4b71c486eb5/42003_2024_6520_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef3/11233613/5da3fd73c923/42003_2024_6520_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef3/11233613/7bec0648c14b/42003_2024_6520_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef3/11233613/4c0677c4df4d/42003_2024_6520_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef3/11233613/c6bc2061f128/42003_2024_6520_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef3/11233613/889a2f64ae07/42003_2024_6520_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef3/11233613/fbacc5125f59/42003_2024_6520_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef3/11233613/d4b71c486eb5/42003_2024_6520_Fig7_HTML.jpg

相似文献

1
A-to-I RNA co-editing predicts clinical outcomes and is associated with immune cells infiltration in hepatocellular carcinoma.A-to-I RNA 编辑预测肝癌的临床预后并与免疫细胞浸润相关。
Commun Biol. 2024 Jul 9;7(1):838. doi: 10.1038/s42003-024-06520-y.
2
Prognostic analysis and risk assessment based on RNA editing in hepatocellular carcinoma.基于 RNA 编辑的肝细胞癌预后分析与风险评估。
J Appl Genet. 2024 Sep;65(3):519-530. doi: 10.1007/s13353-023-00819-y. Epub 2024 Jan 13.
3
High ratio of resident to exhausted CD4 + T cells predicts favorable prognosis and potentially better immunotherapeutic efficacy in hepatocellular carcinoma.高比例的耗竭 CD4+T 细胞与肝癌患者的良好预后和潜在更好的免疫治疗效果相关。
BMC Cancer. 2024 Sep 17;24(1):1152. doi: 10.1186/s12885-024-12916-0.
4
Identification of Crucial Cancer Stem Cell Genes Linked to Immune Cell Infiltration and Survival in Hepatocellular Carcinoma.鉴定与肝癌中免疫细胞浸润和存活相关的关键癌症干细胞基因。
Int J Mol Sci. 2024 Nov 7;25(22):11969. doi: 10.3390/ijms252211969.
5
Multi-omics identification of a polyamine metabolism related signature for hepatocellular carcinoma and revealing tumor microenvironment characteristics.多组学鉴定肝细胞癌中与多胺代谢相关的特征并揭示肿瘤微环境特征
Front Immunol. 2025 Apr 22;16:1570378. doi: 10.3389/fimmu.2025.1570378. eCollection 2025.
6
ncRNA-mediated SOX4 overexpression correlates with unfavorable outcomes and immune infiltration in hepatocellular carcinoma.ncRNA 介导的 SOX4 过表达与肝细胞癌不良预后和免疫浸润相关。
BMC Gastroenterol. 2024 Aug 14;24(1):265. doi: 10.1186/s12876-024-03346-0.
7
Identification of Biomarkers Related to Immune Cell Infiltration in Hepatocellular Carcinoma Using Gene Co-Expression Network.基于基因共表达网络鉴定肝细胞癌中与免疫细胞浸润相关的生物标志物
Pathol Oncol Res. 2021 Apr 2;27:601693. doi: 10.3389/pore.2021.601693. eCollection 2021.
8
METTL1-driven nucleotide metabolism reprograms the immune microenvironment in hepatocellular carcinoma: a multi-omics approach for prognostic biomarker discovery.METTL1驱动的核苷酸代谢重编程肝细胞癌的免疫微环境:一种用于发现预后生物标志物的多组学方法
Front Immunol. 2025 Apr 22;16:1582203. doi: 10.3389/fimmu.2025.1582203. eCollection 2025.
9
TMEM101 expression and its impact on immune cell infiltration and prognosis in hepatocellular carcinoma.跨膜蛋白101(TMEM101)的表达及其对肝细胞癌免疫细胞浸润和预后的影响。
Sci Rep. 2024 Dec 30;14(1):31847. doi: 10.1038/s41598-024-83174-0.
10
Single-cell sequencing combined with bulk RNA seq reveals the roles of natural killer cell in prognosis and immunotherapy of hepatocellular carcinoma.单细胞测序联合批量RNA测序揭示自然杀伤细胞在肝细胞癌预后和免疫治疗中的作用。
Sci Rep. 2025 May 1;15(1):15314. doi: 10.1038/s41598-025-99638-w.

引用本文的文献

1
Deciphering the mechanistic roles of ADARs in cancer pathogenesis, tumor immune evasion, and drug resistance.解读腺苷脱氨酶作用于RNA(ADARs)在癌症发病机制、肿瘤免疫逃逸和耐药性中的机制性作用。
Front Immunol. 2025 Aug 7;16:1621585. doi: 10.3389/fimmu.2025.1621585. eCollection 2025.
2
A-to-I RNA edited POLA2 attains carcinogenesis in prostatic cancer by impeding immune infiltration and upregulating BTBD7.A到I RNA编辑的POLA2通过阻碍免疫浸润和上调BTBD7在前列腺癌中实现致癌作用。
Discov Oncol. 2025 May 14;16(1):759. doi: 10.1007/s12672-025-02449-8.
3
Clinical applications of oligonucleotides for cancer therapy.

本文引用的文献

1
circGLS2 inhibits hepatocellular carcinoma recurrence via regulating hsa-miR-222-3p-PTEN-AKT signaling.环状GLS2通过调控hsa-miR-222-3p-PTEN-AKT信号通路抑制肝细胞癌复发。
Signal Transduct Target Ther. 2023 Feb 17;8(1):67. doi: 10.1038/s41392-022-01275-6.
2
ADAR regulates APOL1 via A-to-I RNA editing by inhibition of MDA5 activation in a paradoxical biological circuit.ADAR 通过抑制 MDA5 的激活来调节 APOL1 的 A-to-I RNA 编辑,形成一个矛盾的生物学回路。
Proc Natl Acad Sci U S A. 2022 Nov;119(44):e2210150119. doi: 10.1073/pnas.2210150119. Epub 2022 Oct 25.
3
Pan-cancer landscape of T-cell exhaustion heterogeneity within the tumor microenvironment revealed a progressive roadmap of hierarchical dysfunction associated with prognosis and therapeutic efficacy.
寡核苷酸在癌症治疗中的临床应用。
Mol Ther. 2025 Jun 4;33(6):2705-2718. doi: 10.1016/j.ymthe.2025.02.045. Epub 2025 Mar 5.
肿瘤微环境中 T 细胞耗竭异质性的泛癌全景揭示了与预后和治疗效果相关的分层功能障碍的渐进路线图。
EBioMedicine. 2022 Sep;83:104207. doi: 10.1016/j.ebiom.2022.104207. Epub 2022 Aug 9.
4
GPC3-targeted immunoPET imaging of hepatocellular carcinomas.GPC3 靶向免疫 PET 显像用于肝细胞癌。
Eur J Nucl Med Mol Imaging. 2022 Jul;49(8):2682-2692. doi: 10.1007/s00259-022-05723-x. Epub 2022 Feb 11.
5
Co-Mutation of FAT3 and LRP1B in Lung Adenocarcinoma Defines a Unique Subset Correlated With the Efficacy of Immunotherapy.肺腺癌中 FAT3 和 LRP1B 的共突变定义了一个与免疫治疗疗效相关的独特亚群。
Front Immunol. 2022 Jan 6;12:800951. doi: 10.3389/fimmu.2021.800951. eCollection 2021.
6
Identification of Prognostic Genes for Colon Cancer through Gene Co-expression Network Analysis.通过基因共表达网络分析鉴定结肠癌的预后基因。
Curr Med Sci. 2021 Oct;41(5):1012-1022. doi: 10.1007/s11596-021-2386-2. Epub 2021 Sep 20.
7
Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response.免疫微环境的空间结构协调肿瘤免疫和治疗反应。
J Hematol Oncol. 2021 Jun 25;14(1):98. doi: 10.1186/s13045-021-01103-4.
8
Conserved pan-cancer microenvironment subtypes predict response to immunotherapy.泛癌种保守的微环境亚型可预测免疫治疗的反应。
Cancer Cell. 2021 Jun 14;39(6):845-865.e7. doi: 10.1016/j.ccell.2021.04.014. Epub 2021 May 20.
9
Oncogenic Recruits an Expansive Transcriptional Network through Mutant p53 to Drive Pancreatic Cancer Metastasis.致癌基因通过突变型 p53 招募一个广泛的转录网络来驱动胰腺癌转移。
Cancer Discov. 2021 Aug;11(8):2094-2111. doi: 10.1158/2159-8290.CD-20-1228. Epub 2021 Apr 10.
10
Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade.治疗性增加 MHC-I 表达可增强免疫检查点阻断。
Cancer Discov. 2021 Jun;11(6):1524-1541. doi: 10.1158/2159-8290.CD-20-0812. Epub 2021 Feb 15.